Reflect Scientific, Inc.
Reflect Scientific, Inc. (RSCF) Financial Performance & Income Statement Overview
Analyze Reflect Scientific, Inc. (RSCF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Reflect Scientific, Inc. (RSCF) Income Statement & Financial Overview
Explore comprehensive income reports for Reflect Scientific, Inc. RSCF, broken down by year and quarter.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $344132.00 | $514023.00 | $590071.00 | $428755.00 |
| Cost of Revenue | $285987.00 | $186197.00 | $231514.00 | $329580.00 |
| Gross Profit | $58145.00 | $327826.00 | $358557.00 | $99175.00 |
| Gross Profit Ratio | $0.17 | $0.64 | $0.61 | $0.23 |
| R&D Expenses | $2349.00 | $3092.00 | $4605.00 | $7375.00 |
| SG&A Expenses | $82312.00 | $87552.00 | $107555.00 | $132304.00 |
| Operating Expenses | $84661.00 | $90644.00 | $112160.00 | $139679.00 |
| Total Costs & Expenses | -$370648.00 | $276841.00 | $491728.00 | $469259.00 |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $18842.00 | $18408.00 | $17999.00 | $17628.00 |
| EBITDA | $1186.00 | $117647.00 | $116342.00 | -$14346.00 |
| EBITDA Ratio | $0.003 | $0.23 | $0.20 | -$0.03 |
| Operating Income | -$26516.00 | $99239.00 | $98343.00 | -$40500.00 |
| Operating Income Ratio | -$0.08 | $0.19 | $0.17 | -$0.09 |
| Other Income/Expenses (Net) | $8858.00 | $10791.00 | $10644.00 | $8533.00 |
| Income Before Tax | -$17658.00 | $110030.00 | $108987.00 | -$31971.00 |
| Income Before Tax Ratio | -$0.05 | $0.21 | $0.18 | -$0.07 |
| Income Tax Expense | $231.00 | $100.00 | $0.00 | $2.00 |
| Net Income | -$17889.00 | $109930.00 | $108987.00 | -$31971.00 |
| Net Income Ratio | -$0.05 | $0.21 | $0.18 | -$0.07 |
| EPS | -$0.00 | $0.001 | $0.001 | -$0.00 |
| Diluted EPS | -$0.00 | $0.001 | $0.001 | -$0.00 |
| Weighted Avg Shares Outstanding | $85.66M | $85.66M | $85.66M | $85.66M |
| Weighted Avg Shares Outstanding (Diluted) | $85.66M | $85.66M | $85.66M | $85.66M |
Over the last four quarters, Reflect Scientific, Inc.'s revenue moved from $428755.00 in Q1 2024 to $344132.00 in Q4 2024. Operating income in Q4 2024 was -$26516.00, with a strong operating margin of -8%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Reflect Scientific, Inc. remained robust at $1186.00, reflecting operational efficiency. Net income dropped to -$17889.00, with an EPS of -$0.00. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan